Latest ondansetron Stories
NEW YORK, March 1, 2015 /PRNewswire-USNewswire/ -- A new study published this month is adding to an accumulating body of evidence suggesting that ondansetron, an anti-nausea medication sold
National pharmaceutical and medical device law firm, the Onder Law Firm, provides comprehensive fetal risk information and no-cost, confidential case review to families whose baby was born with
DALLAS, January 22, 2015 /PRNewswire/ -- The Global Anxiety Disorders Market 2015-2019 research report, now available with ReportsnReports.com, says that in addition to
BUDAPEST, Hungary and DUBLIN, Jan. 20, 2015 /PRNewswire/ -- Gedeon Richter Plc.
MILAN, December 19, 2014 /PRNewswire/ -- - First New Chemical Entity (NCE) in 10 years to receive a positive opinion from CHMP for the treatment
MOUNTAIN VIEW, Calif. and BARCELONA, Spain, Dec. 11, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A.
SAN DIEGO, Oct. 30, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S.
LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 mug/kg, Palonosetron, administered as a singledose, is as effective as ondansetron 0.15 mg/kg given
SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.